The weekly litigation news digest is live. Subscribe now

IP Verse

Highly Sensitive Cell-Based Assay To Detect The Presence Of Active Botulinum Neurotoxin Serotype-A - EP3279335

The patent EP3279335 was granted to Abel on Mar 10, 2021. The application was filed on Dec 28, 2012 under application number EP17178062A. The patent is currently recorded with a legal status of "Revoked".

EP3279335

ABEL
Application Number
EP17178062A
Filing Date
Dec 28, 2012
Status
Revoked
Aug 19, 2022
Publication Date
Mar 10, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MERZ PHARMADec 8, 2021ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB -

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20100723474
DESCRIPTIONUS2004166514
DESCRIPTIONUS2004220386
DESCRIPTIONUS2008096248
DESCRIPTIONUS2008161543
DESCRIPTIONUS2008241881
DESCRIPTIONUS2010112727
DESCRIPTIONUS2011287517
DESCRIPTIONUS7223577
DESCRIPTIONUS7419676
DESCRIPTIONUS8198034
OPPOSITIONWO2009114748
OPPOSITIONWO2010105234
SEARCHWO2009114748
SEARCHWO2010105234

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents